Nephrotic syndrome as first symptom of Crohn's disease;Nephrotisches Syndrom als Erstsymptom eines M. Crohn

Zeitschrift fur Gastroenterologie

Volumn 34, Issue 11, 1996, Pages 757-762

  Kullmann, F ^a,b   Kullmann, M ^a   Leser, H G ^a   Kramer B K ^a   Riegger, A J G ^a   Scholmerich J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

azathioprine; Crohn's disease; nephrotic syndrome; renal amyloidosis

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CARVEDILOL; FUROSEMIDE; NITRENDIPINE; PROTEIN;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DIET; EDEMA; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY AMYLOIDOSIS; MALE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PANCYTOPENIA; PROTEINURIA;

AMYLOIDOSIS; AZATHIOPRINE; BIOPSY; CECUM; COMBINED MODALITY THERAPY; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROTIC SYNDROME;

EID: 0029799601     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Cohen AS. Amyloidosis. N Engl J Med 1967; 277: 522-30
2. Glenner GG. Amyloid deposits and amyloidosis. N Engl J Med 1980; 302: 1283-92
3. Husby GH. Amyloidosis. Semin Arthritis Rheum 1992; 22: 67-82
4. De Beer FC, Fagan EA, Hughes GRV et al. Serum amyloid-A-protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 1982; 11: 231-6
5. Witteman EM, Janssen HLA, Hazenberg BPC, Janssen S. Amyloidosis; pathogenese en therapie. Ned Tijdschr Geneeskd 1992; 136: 2318-22
6. Marhaug G, Dowton SB. Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. Baillieres Clin Rheumatol 1994; 8: 553-73
7. Brandt K, Cathcart ES, Cohen AS. A clinical analysis of the course of fourty-two patients with amyloidosis. Am J Med 1968; 44: 955-69
8. Triger DR, Jockes AM. Renal amyloidosis - a fourteen-year follow-up. Quart J Med 1973; 165: 15-40
9. Moschkowitz E. The clinical aspects of amyloidosis. Ann Intern Med 1936; 10: 73-89
10. Gries E, Singer MV, Goebell H. Amyloidose bei Morbus Crohn. Fallvorstellung und Übersicht über die Literatur. Med Klin 1989; 84: 65-71
11. Greenstein AJ, Sachar DB, Nannan Panday AK et al Amyloidosis and inflammatory bowel disease. Medicine 1992; 71: 261-70
12. Adler GM Crohn und Colitits ulcerosa. Berlin, Heidelberg, New York. London, Paris, Tokyo, Hongkong, Barcelona, Budapest, Springer-Verlag 1993: 72-3
13. Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel disease Dis Colon Rectum 1986; 29: 351-4
14. Werther JL, Schapira A, Rubinstein O, Janowitz HD. Amyloidosis in regional enteritis. Am J Med 1969, 29 416-23
15. Gitkind MJ, Wright SC. Amyloidosis complicating inflammatory bowel disease. Dig Dis Sci 1990; 35: 906-8
16. Mir-Madjlessi SH, Brown CH, Hawk WA. Amyloidosis associated with Crohn's disease. Am J Gastroenterol 1972; 58: 563-76
17. Gertz MA Secondary amyloidosis (AA). J Int Med 1992; 232: 517-8
18. Schmidt H, Riemann JF Amyloidose bei Morbus Crohn Dtsch Med Wochenschr 1983; 108: 795-7
19. Steinhoff J, Schulz E, Herbst EW, Fricke L, Sack W. Therapie der Amyloidnephrose bei Morbus Crohn: Plasmapherese plus Azathioprin? Wien Med Wochenschr 1988; 138: 49-54
20. Cohen AS. Amyloidosis. In: Harrisons principles of internal medicine. New York, Hamburg, London, Paris, Sydney, Tokyo, McGraw-Hill 1991: 1417-21
21. Groß MW, Brandstetter K, Deusch K, Lehner K. Sekundäre Amyloidose der Nieren bei M. Crohn: Radiologische Befunde.Röntgenpraxis 1993; 46: 251-3
22. Teppo AM, Maury CPJ. Urinary protein excretion patterns in reactive (secondary) systemic amyloidosis. Rheumatol Int 1988; 8: 213-7
23. Mody GM, Meyers OL. Clinical regression of amyloid nephropathy in a patient with rheumatoid arthritis. S Afr Med J 1988; 73: 55-6
24. Fitchen JH. Amyloidosis and granulomatous ileocolitis. N Engl J Med 1975; 292: 352-3
25. Mandelstam P, Simmons DE, Mitchell B. Regression of amyloid in Crohn's disease after bowel resection. J Clin Gastroenterol 1989; 11 324-6
26. Cérdan FJ, Diez M, Pérez de Oteiza C et al. Amiloidosis renal en un caso de enfermedad de Crohn con afectación de colon y recto. Rev Esp Enf Digest 1991; 80: 123-6
27. Schneider W, Martin P, Meinel K. Amyloidose der Nieren beim M. Crohn. Z Gesamte Inn Med 1988; 43: 494-5
28. Ravid M, Shapira J, Kedar I, Feigl D. Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. Acta Hepato-Gastroenterol 1979; 26: 513-5
29. Becker SA, Bass D, Nissim F. Crohn's ileitis complicated by amyloidosis. J Clin Gastroenterol 1985; 7: 296-300
30. Berglund K, Thysell H, Keller C. Reuslts, principles and pitfalls in the management of renal AA-amyloidosis. a 10-21-year foltow-up of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol 1993; 20: 2051-7
31. Maezawa A, Hiromura K, Mitsuhashi H et al. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis. Clin Nephrol 1994; 42: 30-2
32. Gertz MA, Kyle RA. Phase II trial of alpha-tocopherol (vit. E) in the treatment of primary systemic amyloidosis. Am J Hematol 1990; 34: 55-8
33. Heering P, Kutkuhn B, Frenzel H, Linke RP, Grabensee B. Renal transplantation in amyloid nephropathy. Int Urol Nephrol 1989; 21: 339-47
34. Kilicturgay S, Tokyay R, Arslan G, Bilgin N, Haberal M. The results of transplantation of patients with amyloid nephropathy. Transplant Proc 1992; 24: 1788-9
35. Duda SH, Raible A, Risler T et al. Therapeutische bilaterale Nierenarterienembolisation bei nephrotischem Syndrom. Dtsch Med Wochenschr 1994; 119: 58-62
36. Ewe K, Press AG, Singe C et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterolgoy 1993; 105: 367-72
37. Brogan M, Hiserodt J, Oliver M et al. The effect of 6-mercaptopurine on natural killer cell activities in Crohn's disease J Clin Immunol 1985; 5: 204-11